Jon S. Kuwahara

Tokai Pharmaceuticals

Senior Vice President of Finance and Administration

Overview

Jon S. Kuwahara made an average of $343.9K in compensation at Tokai Pharmaceuticals between 2017 and 2018.

Annual data

2018

In 2018, Jon S. Kuwahara earned a total compensation of $429.6K as Senior Vice President of Finance and Administration at Tokai Pharmaceuticals.

Ranking9,618 out of 10,778
Percentile10.8%

Jon S. Kuwahara's 2018 compensation ranked 9,618th out of 10,778 executive pay records tracked by us this year.

Kuwahara earned more than 10.8% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking1,113 out of 1,199
Percentile7.2%

In the industry group of Drugs, Kuwahara's pay ranked 1,113th out of 1,199 executive pay records tracked by us in 2018.

Kuwahara earned more than 7.2% of executives in this group.

Non-Equity Incentive Plan$70,117
Option Awards$40,636
Salary$281,065
Stock Awards$36,372
Other$1,391
Total$429,581

Kuwahara received $281.1K in salary, which accounts for 65.43% of total compensation.

Kuwahara also received $70.1K in non-equity incentive plan, $40.6K in option awards, $36.4K in stock awards and $1.4K in other compensation.

2017

In 2017, Jon S. Kuwahara earned a total compensation of $258.3K as Senior Vice President of Finance and Administration at Tokai Pharmaceuticals.

Ranking12,794 out of 13,701
Percentile6.6%

Jon S. Kuwahara's 2017 compensation ranked 12,794th out of 13,701 executive pay records tracked by us this year.

Kuwahara earned more than 6.6% of all executives tracked by us in 2018.

Industry groupDrugs
Ranking1,461 out of 1,547
Percentile5.6%

In the industry group of Drugs, Kuwahara's pay ranked 1,461st out of 1,547 executive pay records tracked by us in 2017.

Kuwahara earned more than 5.6% of executives in this group.

Option Awards$136,052
Salary$121,635
Other$575
Total$258,262

Kuwahara received $136.1K in option awards, which accounts for 52.68% of total compensation.

Kuwahara also received $121.6K in salary and $575 in other compensation.